Select Publications
Journal articles
2018, 'Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma', British Journal of Cancer, 119, pp. 693 - 696, http://dx.doi.org/10.1038/s41416-018-0251-2
,2018, 'Oral malignant gastrointestinal neuroectodermal tumour with junctional component mimicking mucosal melanoma.', Pathology, 50, pp. 648 - 653, http://dx.doi.org/10.1016/j.pathol.2018.07.002
,2018, 'Relative frequency and risk factors for long-term opioid therapy following surgery and trauma among adults: A systematic review protocol', Systematic Reviews, 7, http://dx.doi.org/10.1186/s13643-018-0760-3
,2018, 'Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A collaborative report from the International and European Society for Pediatric Oncology DIPG registries', Journal of Clinical Oncology, 36, pp. 1963 - 1972, http://dx.doi.org/10.1200/JCO.2017.75.9308
,2018, 'Quantitative Measurement of Erythrocyte Aggregation as a Systemic Inflammatory Marker by Ultrasound Imaging: A Systematic Review', Ultrasound in Medicine and Biology, 44, pp. 1303 - 1317, http://dx.doi.org/10.1016/j.ultrasmedbio.2018.02.020
,2018, 'DIPG-69. CHARACTERISTICS OF PATIENTS ≥ 10 YEARS OF AGE WITH DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY', Neuro-Oncology, 20, pp. i63 - i63, http://dx.doi.org/10.1093/neuonc/noy059.162
,2018, 'DIPG-70. CLINICAL, RADIOLOGICAL, PATHOLOGICAL AND MOLECULAR CHARACTERISTICS OF CHILDREN <3 YEARS WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG): A REPORT FROM THE INTERNATIONAL DIPG REGISTRY', Neuro-Oncology, 20, pp. i63 - i63, http://dx.doi.org/10.1093/neuonc/noy059.163
,2018, 'GERM-23. INTRACRANIAL GROWING TERATOMA SYNDROME (IGTS): AN INTERNATIONAL RETROSPECTIVE STUDY', Neuro-Oncology, 20, pp. i88 - i88, http://dx.doi.org/10.1093/neuonc/noy059.270
,2018, 'HGG-20. DNA METHYLATION ANALYSIS OF HIGH-GRADE GLIOMA IN PATIENTS WITH MISMATCH REPAIR DEFICIENCIES', Neuro-Oncology, 20, pp. i92 - i93, http://dx.doi.org/10.1093/neuonc/noy059.292
,2018, 'Too many targets, not enough patients: Rethinking neuroblastoma clinical trials', Nature Reviews Cancer, 18, pp. 389 - 400, http://dx.doi.org/10.1038/s41568-018-0003-x
,2018, 'Genomic landscape of pineoblastoma.', Journal of Clinical Oncology, 36, pp. 2028 - 2028, http://dx.doi.org/10.1200/jco.2018.36.15_suppl.2028
,2018, 'NANT 2012-01: Phase 1 study of DFMO and celecoxib with cyclophosphamide and topotecan for relapsed or refractory high-risk neuroblastoma.', JOURNAL OF CLINICAL ONCOLOGY, 36, http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.10558
,2018, 'Targeted doxorubicin-loaded bacterially derived nano-cells for the treatment of neuroblastoma', Molecular Cancer Therapeutics, 17, pp. 1012 - 1023, http://dx.doi.org/10.1158/1535-7163.MCT-17-0738
,2018, 'The development of delta: Using agile to develop a decision aid for pediatric oncology clinical trial enrollment', JMIR Research Protocols, 7, pp. e119, http://dx.doi.org/10.2196/resprot.9258
,2018, 'Dual targeting of mitochondrial function and mTOR pathway as a therapeutic strategy for diffuse intrinsic pontine glioma', Oncotarget, 9, pp. 7541 - 7556, http://dx.doi.org/10.18632/oncotarget.24045
,2017, 'Comprehensive Analysis of Hypermutation in Human Cancer', Cell, 171, pp. 1042 - 1056.e10, http://dx.doi.org/10.1016/j.cell.2017.09.048
,2017, 'PDTM-21. LARGE SCALE TUMOR MUTATIONAL BURDEN ANALYSIS OF PEDIATRIC TUMORS PROVIDES A DIAGNOSTIC TOOL FOR GERMLINE PREDISPOSITION AND REVEALS NOVEL CANDIDATES FOR IMMUNE CHECKPOINT INHIBITION', Neuro-Oncology, 19, pp. vi194 - vi194, http://dx.doi.org/10.1093/neuonc/nox168.785
,2017, 'Investigating the biology of relapsed acute leukemia: Proceedings of the Therapeutic Advances for Childhood Leukemia & Lymphoma (TACL) Consortium Biology Working Group', Pediatric Hematology and Oncology, 34, pp. 355 - 364, http://dx.doi.org/10.1080/08880018.2017.1395937
,2017, 'A novel somatic JAK2 kinase-domain mutation in pediatric acute lymphoblastic leukemia with rapid on-treatment development of LOH', Cancer Genetics, 216-217, pp. 86 - 90, http://dx.doi.org/10.1016/j.cancergen.2017.07.008
,2017, 'The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan disease', Journal of Neuro-Oncology, 132, pp. 323 - 331, http://dx.doi.org/10.1007/s11060-017-2372-5
,2017, 'Genomic insights into diffuse intrinsic pontine glioma', Frontiers in Oncology, 7, pp. 57, http://dx.doi.org/10.3389/fonc.2017.00057
,2017, 'Ganglioglioma arising from desmoplastic medulloblastoma: A case report and review of literature', Pediatrics, 139, http://dx.doi.org/10.1542/peds.2016-1403
,2017, 'Pre-clinical study of panobinostat in xenograft and genetically engineered murine diffuse intrinsic pontine glioma models', PLoS ONE, 12, pp. e0169485, http://dx.doi.org/10.1371/journal.pone.0169485
,2017, 'IMMU-13. LARGE SCALE TUMOR MUTATIONAL BURDEN ANALYSIS OF PEDIATRIC TUMORS PROVIDES A DIAGNOSTIC TOOL FOR GERMLINE PREDISPOSITION AND REVEALS NOVEL CANDIDATES FOR IMMUNE CHECKPOINT INHIBITION', Neuro-Oncology, 19, pp. iv30 - iv30, http://dx.doi.org/10.1093/neuonc/nox083.123
,2017, 'Immune Check Point Inhibitor Treatment for Young Patients with Hypermutant Cancers', Gastroenterology, 152, pp. S141 - S141, http://dx.doi.org/10.1016/s0016-5085(17)30801-6
,2016, 'Molecular transport through large-diameter DNA nanopores.', Nat Commun, 7, pp. 12787, http://dx.doi.org/10.1038/ncomms12787
,2016, 'Polyamine antagonist therapies inhibit neuroblastoma initiation and progression', Clinical Cancer Research, 22, pp. 4391 - 4404, http://dx.doi.org/10.1158/1078-0432.CCR-15-2539
,2016, 'Economics of Musculoskeletal Ultrasound', Current Radiology Reports, 4, http://dx.doi.org/10.1007/s40134-016-0169-5
,2016, 'Case report of spontaneous resolution of a congenital glioblastoma', Pediatrics, 137, pp. e20151241, http://dx.doi.org/10.1542/peds.2015-1241
,2016, 'Testing flow diversion in animal models: a systematic review', Neuroradiology, 58, pp. 375 - 382, http://dx.doi.org/10.1007/s00234-015-1635-0
,2016, 'The wide-ranging clinical implications of the short telomere syndromes', Internal Medicine Journal, 46, pp. 393 - 403, http://dx.doi.org/10.1111/imj.12868
,2016, 'The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs', Oncotarget, 7, pp. 79217 - 79232, http://dx.doi.org/10.18632/oncotarget.12640
,2016, 'Predictors of success of phase 2 paediatric oncology clinical trials', European Journal of Cancer, 69, pp. S63 - S64, http://dx.doi.org/10.1016/s0959-8049(16)32778-2
,2015, 'Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma', Science Translational Medicine, 7, pp. 312ra176, http://dx.doi.org/10.1126/scitranslmed.aab1803
,2015, 'Inequities in postnatal care in low-and middle-income countries: A systematic review and meta-analysis', Bulletin of the World Health Organization, 93, pp. 259 - 270, http://dx.doi.org/10.2471/BLT.14.140996
,2015, 'Never say never', Journal of Clinical Oncology, 33, pp. 518 - 520, http://dx.doi.org/10.1200/JCO.2014.58.7717
,2015, 'Efficacy of treatments and pain management for trapeziometacarpal (thumb base) osteoarthritis: Protocol for a systematic review', BMJ Open, 5, http://dx.doi.org/10.1136/bmjopen-2015-008904
,2014, 'Nelarabine in Combination with Etoposide and Cyclophosphamide Is Active in First Relapse of Childhood T-Acute Lymphocytic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LL)', Blood, 124, pp. 795 - 795, http://dx.doi.org/10.1182/blood.v124.21.795.795
,2014, 'Outcomes in multifocal neuroblastoma as part of the neurocristopathy syndrome', Pediatrics, 134, http://dx.doi.org/10.1542/peds.2013-3340
,2014, 'Protocol for a systematic review of the association between chronic stress during the life course and telomere length', Systematic Reviews, 3, http://dx.doi.org/10.1186/2046-4053-3-40
,2014, 'Antibody therapy for pediatric leukemia', Frontiers in Oncology, 4, pp. 1 - 10, http://dx.doi.org/10.3389/fonc.2014.00082
,2014, 'Association between nutritional status and the immune response in HIV + patients under HAART: Protocol for a systematic review', Systematic Reviews, 3, http://dx.doi.org/10.1186/2046-4053-3-9
,2014, 'Molecular profiling of childhood cancer: Biomarkers and novel therapies', BBA Clinical, 1, pp. 59 - 77, http://dx.doi.org/10.1016/j.bbacli.2014.06.003
,2014, '421 Molecular profiling for factors predicting sensitivity or resistance to therapy in relapsed child cancer', European Journal of Cancer, 50, pp. 135, http://dx.doi.org/10.1016/s0959-8049(14)70547-7
,2013, 'Protocol for a systematic review on inequalities in postnatal care services utilization in low- and middle-income countries.', Systematic reviews, 2, pp. 55, http://dx.doi.org/10.1186/2046-4053-2-55
,2013, 'A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia', Nature Genetics, 45, pp. 1226 - 1231, http://dx.doi.org/10.1038/ng.2754
,2013, 'Transplant-related mortality following allogeneic hematopoeitic stem cell transplantation for pediatric acute lymphoblastic leukemia: 25-year retrospective review', Pediatric Blood and Cancer, 60, pp. 1520 - 1527, http://dx.doi.org/10.1002/pbc.24559
,2012, 'Erratum: Treatment of diabetic neuropathy and neuropathic pain: How far have we come? (Diabetes Care (2008) 31 Suppl. 2, (S255-S261) DOI: 10.2337/dc08-s263)', Diabetes Care, 35, pp. 456, http://dx.doi.org/10.2337/dc12-rt02
,2012, 'Australian paediatric surveillance unit study of haemoglobinopathies in australian children', Journal of Paediatrics and Child Health, 48, pp. 356 - 360, http://dx.doi.org/10.1111/j.1440-1754.2011.02236.x
,2012, 'Neonatal Sweet Syndrome: A potential marker of serious systemic illness', Pediatrics, 129, pp. e1353 - e1359, http://dx.doi.org/10.1542/peds.2011-1854
,